Atorvastatin and Ledipasvir and sofosbuvir interaction

Atorvastatin and Ledipasvir and sofosbuvir: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Ledipasvir and sofosbuvir label · effective 2025-01-10

Major

Coadministration of ledipasvir and sofosbuvir with rosuvastatin is not recommended. atorvastatin ↑ atorvastatin Coadministration of ledipasvir and sofosbuvir with atorvastatin may be associated with increased risk of myopathy, including rhabdomyolysis.

Drug interactionsnames AtorvastatinView label on DailyMed
Moderate

HMG-CoA Reductase Inhibitors: rosuvastatin ↑ rosuvastatin Coadministration of ledipasvir and sofosbuvir with rosuvastatin may significantly increase the concentration of rosuvastatin, which is associated with increased risk of myopathy, including rhabdomyolysis.

Drug interactionsby drug classView label on DailyMed
Moderate

Monitor closely for HMG-CoA reductase inhibitor-associated adverse reactions, such as myopathy and rhabdomyolysis.

Drug interactionsby drug classView label on DailyMed

From the Atorvastatin (Lipitor) label · effective 2024-04-15

Moderate

Cases of myopathy/rhabdomyolysis have been reported with atorvastatin co-administered with lipid modifying doses (>1 gram/day) of niacin, fibrates, colchicine, and ledipasvir plus sofosbuvir [see Adverse Reactions (6.1) ] .

Warnings and precautionsnames Ledipasvir and sofosbuvirView label on DailyMed
Moderate

• Consider the risk/benefit of concomitant use of ledipasvir plus sofosbuvir with LIPITOR.

Drug interactionsnames Ledipasvir and sofosbuvirView label on DailyMed
Minor

Cases of myopathy and rhabdomyolysis have been reported with concomitant use of ledipasvir plus sofosbuvir with LIPITOR.

Drug interactionsnames Ledipasvir and sofosbuvirView label on DailyMed
Minor

Examples: Tipranavir plus ritonavir, glecaprevir plus pibrentasvir, lopinavir plus ritonavir, simeprevir, saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir, elbasvir plus grazoprevir, letermovir, nelfinavir, and ledipasvir plus sofosbuvir.

Drug interactionsnames Ledipasvir and sofosbuvirView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.